Results 131 to 140 of about 1,518,675 (340)

COVID 19 Vaccine opposition-hesitancy

open access: yesKlinik Psikiyatri Dergisi, 2021
Mehmet Yumru, Sevcan Karakoç Demirkaya
doaj   +1 more source

The COVID-19 vaccination

open access: yesMedicina Clínica (English Edition), 2021
Casas, Irma, Mena, Guillermo
openaire   +4 more sources

Analysis of interstitial lung disease in pharmacovigilance databases: Coding challenges and interpretation biases—An update

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aim Clinically, interstitial lung disease (ILD) is a heterogeneous group of respiratory disorders. Due to their low incidence, pharmacovigilance database analysis is useful to detect them. Precise diagnosis is challenging as well as coding in these databases. Query criteria are among the key elements for a good signal detection.
Romane Freppel   +4 more
wiley   +1 more source

Predicting intention to receive COVID-19 vaccine among the general population using the health belief model and the theory of planned behavior model

open access: yesBMC Public Health, 2020
Background This study aim to explore the intentions, motivators and barriers of the general public to vaccinate against COVID-19, using both the Health Belief Model (HBM) and the Theory of Planned Behavior (TPB) model.
Liora Shmueli
semanticscholar   +1 more source

Access to the COVID-19 Vaccine

open access: yesInternational Journal of Environmental Research and Public Health, 2022
As of 31 August 2022, 599,825,400 confirmed coronavirus disease 2019 (COVID-19) cases and 6,469,458 deaths have been reported globally [...]
openaire   +2 more sources

Population pharmacokinetic/pharmacodynamic modelling to evaluate favipiravir in combination with lopinavir–ritonavir in patients with COVID‐19

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims The repurposed use of favipiravir in COVID‐19 has been reported to have limited clinical efficacy, yet it has been widely used in some countries. Favipiravir causes mutagenesis in RNA viruses, and it is currently unknown whether it may have a measurable effect on the virus in humans.
Akosua A. Agyeman   +9 more
wiley   +1 more source

[COVID-19 vaccines: the facts].

open access: yesNederlands tijdschrift voor geneeskunde, 2021
Contains fulltext : 237523.pdf (Publisher’s version ) (Open Access)
Maas, D.P.M.S.M.   +3 more
openaire   +2 more sources

Decoding RNA regulation: Challenges and opportunities for RNA‐based therapies in Europe

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Abstract RNA‐based medicinal products represent a promising frontier in personalised medicine, offering sequence‐specific disease targeting at various molecular levels, yet their clinical translation in the European Union (EU) may be hindered by regulatory uncertainty around definitions and evidence requirements; this study therefore aims to identify ...
Olivia C. Lewis   +4 more
wiley   +1 more source

COVID-19 Vaccine Acceptance and Hesitancy among Nurses in Thailand: Implications, Challenges, and Future Prospects for Attitudes and Vaccine Literacy

open access: yesVaccines
Nurses are healthcare workers at high risk of contracting COVID-19 and are prioritized for COVID-19 vaccination. This study aimed to explore COVID-19 vaccine acceptance, vaccine literacy, and attitudes toward COVID-19 vaccines, and determine factors ...
Nipaporn Butsing   +4 more
doaj   +1 more source

Animals, vaccines, and COVID-19

open access: yesEndeavour, 2021
Animals, especially mammals, have played a critical role in the COVID-19 pandemic. The COVID-19 virus originated in animals, and the virus can jump back and forth between humans and animals. Moreover, animals have been central to the development of the various vaccines against the virus now employed around the world, continuing a long history.
openaire   +2 more sources

Home - About - Disclaimer - Privacy